Kazakhstan busts massive fake vodka ring producing 12,000 counterfeit bottles
Kazakhstan busts massive fake vodka ring producing 12,000 counterfeit bottles
Authorities in Abai Region have shut down an illegal alcohol production operation, Liter.kz reports, citing the Financial Monitoring Agency.
According to the agency, a resident of Semey had set up an unlicensed underground workshop. The facility, operating out of garages and other premises, produced counterfeit spirits by diluting alcohol with water and bottling the mixture in glass containers under the guise of well-known brands.
To lend the products an air of legitimacy, the operation used forged excise stamps.
"During raids, investigators seized over 12,000 bottles of counterfeit alcohol labeled as Finnish Ice and Siberian Frost, more than 8,000 empty bottles, around 10,000 liters of alcohol-based liquid, and production equipment. A court has ordered the seizure of the private home housing the workshop, as well as three vehicles used to transport the goods. The suspect has been placed under travel restrictions while the investigation continues," the agency stated.
The Financial Monitoring Agency warns that consuming counterfeit alcohol poses a serious risk to health and life.
Kazakhstan busts massive fake vodka ring producing 12,000 counterfeit bottles
A hidden workshop in Kazakhstan flooded markets with toxic fake vodka—branded as premium labels. Now, the mastermind faces justice and a travel ban.
Latvian Shopper Falls Ill After Eating Mislabelled 'Desi Ghee' Containing Palm Oil
What was sold as pure ghee turned out to be palm oil—leaving one buyer hospitalized. Now, authorities are cracking down on deceptive food labels.
How journalism's legacy favors transformative leaders over forgotten founders
The press demands transparency from others but rarely examines its own origins. Why do iconic newspapers erase their founders while glorifying later leaders? A deeper look at journalism's selective memory.
Lilly acquires Centessa for $6.3B to boost sleep disorder drug pipeline
A bold $6.3B bet on sleep science. Lilly's takeover of Centessa could reshape treatment for narcolepsy—if clinical trials deliver.